The Outcome of Unselected Patients with Chronic Myeloid
Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In
the First Line and the Prognostic Value of ELN Defined
Responses-Population Based Analysis of 458 Patients Treated
Between 2003-2009.

a 2010

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.

KLAMOVÁ, Hana; Daniela ŽÁČKOVÁ; Edgar FABER; Katerina STEINEROVA; Michal KARAS et al.

Základní údaje

Originální název

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.

Autoři

Vydání

52nd Annual meeting ASH in Blood, 2010

Další údaje

Jazyk

čeština

Typ výsledku

Konferenční abstrakt

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 10.558

Označené pro přenos do RIV

Organizační jednotka

Lékařská fakulta

ISSN

UT WoS

000289662201342

Změněno: 18. 1. 2011 15:06, Jitka Firešová

Citovat

KLAMOVÁ, Hana; Daniela ŽÁČKOVÁ; Edgar FABER; Katerina STEINEROVA; Michal KARAS; Eva DEMECKOVA; Jaroslava VOGLOVÁ; Ludmila DEMITROVICOVA; Elena TOTHOVA; Juraj CHUDEJ; Imrich MARKULJAK; Tomas KOZAK; Eduard CMUNT; Marie JAROSOVA; Katerina MACHOVA-POLAKOVA; Kyra MICHALOVA; Ladislav DUŠEK; Jan MUŽÍK; Martin MISTRIK; Jiří MAYER; Marek TRNENY a Karel INDRAK. The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009. In 52nd Annual meeting ASH in Blood. 2010. ISSN 0006-4971.

@proceedings{920937,
   author = {Klamová, Hana and Žáčková, Daniela and Faber, Edgar and Steinerova, Katerina and Karas, Michal and Demeckova, Eva and Voglová, Jaroslava and Demitrovicova, Ludmila and Tothova, Elena and Chudej, Juraj and Markuljak, Imrich and Kozak, Tomas and Cmunt, Eduard and Jarosova, Marie and MachovaandPolakova, Katerina and Michalova, Kyra and Dušek, Ladislav and Mužík, Jan and Mistrik, Martin and Mayer, Jiří and Trneny, Marek and Indrak, Karel},
   booktitle = {52nd Annual meeting ASH in Blood},
   language = {cze},
   title = {The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.},
   year = {2010}
}

TY  - CONF
ID  - 920937
AU  - Klamová, Hana - Žáčková, Daniela - Faber, Edgar - Steinerova, Katerina - Karas, Michal - Demeckova, Eva - Voglová, Jaroslava - Demitrovicova, Ludmila - Tothova, Elena - Chudej, Juraj - Markuljak, Imrich - Kozak, Tomas - Cmunt, Eduard - Jarosova, Marie - Machova-Polakova, Katerina - Michalova, Kyra - Dušek, Ladislav - Mužík, Jan - Mistrik, Martin - Mayer, Jiří - Trneny, Marek - Indrak, Karel
PY  - 2010
TI  - The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.
ER  -

KLAMOVÁ, Hana; Daniela ŽÁČKOVÁ; Edgar FABER; Katerina STEINEROVA; Michal KARAS; Eva DEMECKOVA; Jaroslava VOGLOVÁ; Ludmila DEMITROVICOVA; Elena TOTHOVA; Juraj CHUDEJ; Imrich MARKULJAK; Tomas KOZAK; Eduard CMUNT; Marie JAROSOVA; Katerina MACHOVA-POLAKOVA; Kyra MICHALOVA; Ladislav DUŠEK; Jan MUŽÍK; Martin MISTRIK; Jiří MAYER; Marek TRNENY a Karel INDRAK. The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009. In \textit{52nd Annual meeting ASH in Blood}. 2010. ISSN~0006-4971.

Přehled o publikaci